Table 1.
Baseline characteristics of the study population, by REGEN-COV status
| Total participants (N = 1583) | Non-treated participants (N = 1296) | Treated with REGEN-COV (N = 289) | |
|---|---|---|---|
| Age [Mean(SD), median (IQR)] | 65 (14), 67 (58,74) | 65 (14), 67 (58,74) | 66 (14), 68 (58,76) |
| Age group, in years | |||
| 19–29 | 12 (0.8%) | 10 (0.8%) | 2 (0.7%) |
| 30–39 | 51 (3.2%) | 44 (3.4%) | 7 (2.4%) |
| 40–49 | 192 (12%) | 157 (12%) | 34 (12%) |
| 50–59 | 195 (12%) | 163 (13%) | 33 (11%) |
| 60–69 | 475 (30%) | 390 (30%) | 86 (30%) |
| 70–74 | 266 (17%) | 221 (17%) | 44 (15%) |
| 75+ | 392 (25%) | 311 (24%) | 83 (29%) |
| Population sector | |||
| General Jewish | 1133 (72%) | 929 (72%) | 205 (71%) |
| Arab | 347 (22%) | 282 (22%) | 66 (23%) |
| Orthodox Jewish | 103 (6.5%) | 85 (6.6%) | 18 (6.2%) |
| Sex | |||
| Female | 819 (52%) | 671 (52%) | 149 (52%) |
| Male | 764 (48%) | 625 (48%) | 140 (48%) |
| Socioeconomic status | |||
| Low | 1078 (68%) | 890 (69%) | 189 (65%) |
| Medium | 468 (30%) | 383 (30%) | 86 (30%) |
| High | 36 (2.3%) | 22 (1.7%) | 14 (4.8%) |
| Missing | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) |
| Flu vaccination in the last five years | |||
| 0 | 422 (27%) | 368 (28%) | 55 (19%) |
| 1 | 207 (13%) | 168 (13%) | 39 (13%) |
| 2 | 180 (11%) | 148 (11%) | 32 (11%) |
| 3 | 165 (10%) | 131 (10%) | 34 (12%) |
| 4 | 213 (13%) | 155 (12%) | 58 (20%) |
| 5 | 396 (25%) | 326 (25%) | 71 (25%) |
| Body mass index (kg/m2) | |||
| Normal | 372 (23%) | 66 (23.0%) | 306 (24.0%) |
| Obese | 508 (32%) | 126 (44.0%) | 561 (43.0%) |
| Overweight | 687 (43%) | 92 (32.0%) | 416 (32.0%) |
| Underweight | 18 (1.1%) | 5 (1.7%) | 13 (1.0%) |
| Smoking status | |||
| Current smoker | 184 (12%) | 141 (11%) | 41 (14%) |
| Past smoker | 393 (25%) | 318 (25%) | 75 (26%) |
| Non-smoker | 1006 (64%) | 837 (65%) | 173 (60%) |
| Recent full vaccination | 1187 (75%) | 1010 (78%) | 176 (61%) |
| First vaccination dose | |||
| Unvaccinated | 513 (32%) | 415 (32%) | 99 (34%) |
| 0–3 weeks | 692 (44%) | 573 (44%) | 121 (42%) |
| 4–7 weeks | 190 (12%) | 162 (12%) | 27 (9.3%) |
| 8–10 weeks | 121 (7.6%) | 102 (7.9%) | 19 (6.6%) |
| 11–19 weeks | 57 (3.6%) | 39 (3.0%) | 18 (6.2%) |
| ≥20 weeks | 10 (0.6%) | 5 (0.4%) | 5 (1.7%) |
| Chronic conditions | |||
| Cancer | 84 (5.3%) | 59 (4.6%) | 25 (8.7%) |
| Chronic kidney disease | 313 (20%) | 227 (18%) | 87 (30%) |
| Respiratory diseases | 254 (16.1%) | 199 (15.4%) | 57 (19.7%) |
| Cardiovascular disease | 475 (30%) | 233 (18%) | 116 (41.0%) |
| Pregnancy | 11 (0.7%) | 9 (0.7%) | 2 (0.7%) |
| Diabetes | 552 (34.9%) | 427 (32.9%) | 125 (43.1%) |
| Hypertension | 731 (46%) | 573 (44%) | 158 (55%) |
| Immunosuppression | 91 (5.7%) | 74 (5.7%) | 17 (5.9%) |
| Neurological disease | 180 (11%) | 143 (11%) | 38 (13%) |
| Liver disease | 72 (4.5%) | 51 (3.9%) | 21 (7.3%) |
Abbreviations: IQR interquartile range.